Abstract

This study investigated T-cell activation markers HLA-DR and CD69 in both naive (CD45RA+) and memory (CD45RA−) CD4+as well as CD8+T cells in peripheral blood of patients with autoimmune thyroiditis (AT,N= 28) or hyperthyroid untreated Graves’ disease (GDH,N= 34) using three-color flow cytometry. It was demonstrated that patients with AT, but not those with GDH, expressed increased amounts of HLA-DR antigen compared to healthy subjects (HS,N= 26) on total CD4+(AT: 14.1%; GDH: 11.3%; HS: 10.9%) and CD8+cells (AT: 31.9%; GDH: 23.5%; HS: 19.4%) as well as on CD45RA−CD4+cells (AT: 11.2%; GDH: 7.7%; HS: 7.9%). In GDH (+71%) and AT (+91%) only the proportion of HLA-DR+CD45RA+CD8+cells was increased vs HS. Furthermore, euthyroid GD patients on methimazole (GDE,N= 22) displayed greater HLA-DR+expression on total and CD45RA−cells within both CD4+(+37 and 40%, respectively) and CD8+cells (+47 and 93%, respectively) than GDH. In addition, total and CD45RA+CD4+and CD8+cells were increased vs HS. In contrast, proportions of CD69 positive T cells were increased in AT and GDH on total CD4+(+97 and 74%, respectively) and CD8+(+95 and 68%, respectively) cells and all subsets thereof (except for CD45RA−cells in GDH), but normalized upon thyrostatic treatment. We conclude that patients with autoimmune thyroid disease harbor an almost twofold greater proportion vs HS of (a) HLA-DR+CD45RA+CD8+T cells, and of (b) CD69 on total CD4+and CD8+cells, and an even more marked elevation on their CD45RA+subset in AT and untreated GD. In addition, (c) thyrostatic treatment by methimazole in GD is accompanied by a further increase in circulating HLA-DR+CD4+and CD8+cells and their CD45RA−subsets, but decreased CD69 expression. These data suggest association of HLA-DR expression with ongoing autoimmunity, while increased CD69 expression relates in part also to elevated thyroid hormone concentration in GDH.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.